Nationwide Children's Research News
Viewing: 251-260 of 353 | All
Oct 29, 2012
Nationwide Childrens Hospital Partners with Silicon Valley to Market High-End Diagnostic and Medical Research Software
The latest significant biomedical informatics technology is not coming from the biotech industry or a university. In fact, it’s coming from a children’s hospital.
Oct 05, 2012
Exon-Skipping Shows Promise in Duchenne Muscular Dystrophy
Results from a Phase IIb extension trial of the drug eteplirsen show an increased ability to walk in boys with Duchenne muscular dystrophy Eteplirsen, a drug that skips exon 51 of the dystrophin gene, may improve quality of life for patients with Duchenne muscular dystrophy and slow disease
Sep 27, 2012
New Intervention May Help Identify and Improve Care for Adolescents at Risk for Suicide
Investigators at Nationwide Children’s Hospital and Cincinnati Children’s Hospital Medical Center are hoping to better identify adolescents at risk for suicide and improve how these at-risk children receive follow up mental health treatment.
Sep 10, 2012
Nationwide Children's Hospital Develops Prototype for Safer, Child-Resistant Spray Bottle
Researchers at The Research Institute at Nationwide Children’s Hospital, in partnership with The Ohio State University have developed a prototype for child-resistant spray bottles for household cleaning products.
Aug 13, 2012
Center for Injury Research and Policy Awarded CDC Injury Control Research Center Designation for an Additional Five Years
The Centers for Disease Control and Prevention (CDC) has renewed the designation of the Center for Injury Research and Policy (CIRP) of The Research Institute at Nationwide Children’s Hospital as one of the agency’s Injury Control Research Centers (ICRCs).
Aug 06, 2012
New Study Examines Injuries to U.S. Workers with Disabilities
A new study conducted by researchers at the Center for Injury Research and Policy of The Research Institute at Nationwide Children’s Hospital and The Ohio State University compared medically attended noncccupational and occupational injuries among U.S. workers with and without disabilities.
Jul 23, 2012
RNA Interference May Provide the First Therapy for Facioscapulohumeral Muscular Dystrophy
Scientists may one day be able to treat the third most common muscular dystrophy, facioscapulohumeral muscular dystrophy (FSHD), by taking advantage of a system within living cells that helps control gene activation.
Jul 18, 2012
Genomics: Colorectal cancer characterized
The genome-wide characterization of colorectal carcinoma was published online today in the journal, Nature. Nationwide Children’s Hospital was one of several institutions involved in this study.
Jul 03, 2012
New Study Finds Increase in Track-Related Injuries Among Youth in the United States
With the 2012 summer Olympic games about to take place in London, children everywhere are looking forward to watching their sports idols and role models take center stage.
Jun 21, 2012
Celebrex-Derived Drug Targets Common Childhood Bone Tumor
Jiayuh Lin, PhD, and colleagues at Nationwide Children’s Hospital have developed a drug to target the most common cancerous bone tumor in children, osteosarcoma, using a version of the FDA-approved drug, Celebrex.